our reviews page to see a complete list of reviews in the mesenchymal cell research field.
StemGenex® Announces Newest Stem Cell Treatment for COPD Patients
StemGenex® announced the newest therapy to assist patients diagnosed with COPD. StemGenex believes a new therapy delivering adipose derived mesenchymal cells directly to the inflamed lungs may reduce the complications associated with COPD including shortness of breath, coughing, heart problems and more. [PR Newswire Association LLC]
Judges Side with FDA on Stem Cells
The D.C. Circuit Court of Appeals ruled that culturing a patient’s stem cells for therapeutic use falls under the aegis of the US Food and Drug Administration (FDA). FDA has said therapeutic stem cells should be regulated as drugs. [The Scientist]